The US Food and Drug Administration (USFDA) has successfully completed the inspection at Dishman Carbogen Amcis’ Bavla facility on October 26, 2018. The inspection was concluded without any major or critical observations.
Thus, the company's facilities in Bavla and Naroda in India, multiple facilities in Switzerland and the Netherlands continue to be approved by the USFDA.
Dishman Carbogen Amcis provides innovative solutions for the development and supply of drug substances and drug products to the pharmaceutical and biopharmaceutical industries.
